Journal of HematotherapyVol. 2, No. 1 T-Cell Depletion for Allogeneic Bone Marrow Transplantation: Impact on Graft-Versus-Host Disease, Engraftment, and Graft-Versus-LeukemiaRICHARD CHAMPLINRICHARD CHAMPLINSearch for more papers by this authorPublished Online:8 May 2009https://doi.org/10.1089/scd.1.1993.2.27AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byPromiscuity of the AlloHLA-A2 Restricted T Cell Repertoire Hampers the Generation of Minor Histocompatibility Antigen-specific Cytotoxic T Cells across HLA BarriersBiology of Blood and Marrow Transplantation, Vol. 13, No. 2Cellular adoptive immunotherapy after allogeneic stem cell transplantationCurrent Opinion in Oncology, Vol. 17, No. 6Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioningBritish Journal of Haematology, Vol. 128, No. 5Adoptive Immunotherapy in Stem Cell Transplantation9 April 2013Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes30 June 2003 | Gene Therapy, Vol. 10, No. 14Phenotypic analysis of human BM T-cell depleted by soybean lectin agglutination and E rosetting with sheep RBC: Relative enrichment of N K cells and a CD3+ ,CD2−dim populationCytotherapy, Vol. 5, No. 1Generation of minor histocompatibility antigen HA-1–specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantationBlood, Vol. 100, No. 2Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignanciesSeminars in Hematology, Vol. 39, No. 1Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?9 August 2001 | Bone Marrow Transplantation, Vol. 28, No. 1CD34 Selection Using Immunomagnetic BeadsInnovative Approaches for Allogeneic Blood and Marrow Transplantation for Treatment of Hematological Malignancies10 June 2013Requirement of Endogenous Stem Cell Factor and Granulocyte-Colony-Stimulating Factor for IL-17-Mediated Granulopoiesis1 May 2000 | The Journal of Immunology, Vol. 164, No. 9What Is an Accurate Risk/Benefit Ratio for Umbilical Cord Cell Transplantation in Children and Adults?Cell SeparationSummary and Future DirectionsImmunotherapy With Interleukin 2 After Bone Marrow Trnsplantation (BMT)Clinical Immunology Newsletter, Vol. 17, No. 5Post-bone marrow transplant use of immunotherapyT-Cells, Graft-Versus-Host Disease, and Graft-Versus-LeukemiaOptimizing the Composition of Bone Marrow for Allogeneic Transplantation RICHARD CHAMPLIN27 March 2009 | Journal of Hematotherapy, Vol. 4, No. 1 Volume 2Issue 1Jan 1993 To cite this article:RICHARD CHAMPLIN.T-Cell Depletion for Allogeneic Bone Marrow Transplantation: Impact on Graft-Versus-Host Disease, Engraftment, and Graft-Versus-Leukemia.Journal of Hematotherapy.Jan 1993.27-42.http://doi.org/10.1089/scd.1.1993.2.27Published in Volume: 2 Issue 1: May 8, 2009PDF download